Cargando…
Experimental ASXL1 ‐Mediated Clonal Hematopoiesis Promotes Inflammation and Accelerates Heart Failure
Autores principales: | Min, Kyung‐Duk, Polizio, Ariel H., Kour, Anupreet, Thel, Mark C., Walsh, Kenneth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673733/ https://www.ncbi.nlm.nih.gov/pubmed/36129058 http://dx.doi.org/10.1161/JAHA.122.026154 |
Ejemplares similares
-
Retrospective analysis of somatic mutations and clonal hematopoiesis in astronauts
por: Brojakowska, Agnieszka, et al.
Publicado: (2022) -
TP53-mediated therapy-related clonal hematopoiesis contributes to doxorubicin-induced cardiomyopathy by augmenting a neutrophil-mediated cytotoxic response
por: Sano, Soichi, et al.
Publicado: (2021) -
Author Correction: Retrospective analysis of somatic mutations and clonal hematopoiesis in astronauts
por: Brojakowska, Agnieszka, et al.
Publicado: (2022) -
The Cancer Therapy-Related Clonal Hematopoiesis Driver Gene Ppm1d Promotes Inflammation and Non-Ischemic Heart Failure in Mice
por: Yura, Yoshimitsu, et al.
Publicado: (2021) -
Clonal Hematopoiesis: A New Step Linking Inflammation to Heart Failure
por: Yura, Yoshimitsu, et al.
Publicado: (2020)